Alpha Tau Medical (DRTS) Other Non-Current Assets (2020 - 2026)
Alpha Tau Medical (DRTS) posted quarterly Other Non-Current Assets of $462000.0 for Q1 2026, up 5.24% year-on-year from $439000.0 in Q1 2025, and down 3.55% on a QoQ basis from $479000.0 in Q4 2025.
Alpha Tau Medical (DRTS) Other Non-Current Assets (2020 - 2026) Analysis & Trends
Alpha Tau Medical (DRTS) has reported Other Non-Current Assets for 7 consecutive years, with $462000.0 the latest figure, recorded in Q1 2026.
- Quarterly Other Non-Current Assets rose 5.24% year-over-year to $462000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $462000.0 (up 5.24% YoY) and the FY2025 annual result came in at $479000.0, up 10.88% from the prior year.
- Other Non-Current Assets retreated to $462000.0 in Q1 2026 per DRTS's latest filing, from $479000.0 in the prior quarter.
- Over the last five years, Other Non-Current Assets for DRTS reached as high as $223.0 million in Q1 2022 and fell as low as $391000.0 in Q4 2022.
- A 5-year average of $13.6 million and a median of $441000.0 in 2023 frame the typical range for Other Non-Current Assets.
- The largest YoY upside for Other Non-Current Assets was 20.46% in 2023 against a maximum downside of 99.8% in 2023.
- Year by year, Other Non-Current Assets stood at $391000.0 in 2022, then grew by 20.46% to $471000.0 in 2023, then declined by 8.28% to $432000.0 in 2024, then advanced by 10.88% to $479000.0 in 2025, then fell by 3.55% to $462000.0 in 2026.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $462000.0, $479000.0, and $472000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Alpha Tau Medical | 1.19 Bn | 1.11 Bn | - | 462,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 462,000.00 |
| Dec 31, 2025 | 479,000.00 |
| Sep 30, 2025 | 472,000.00 |
| Jun 30, 2025 | 463,000.00 |
| Mar 31, 2025 | 439,000.00 |
| Dec 31, 2024 | 432,000.00 |
| Sep 30, 2024 | 438,000.00 |
| Jun 30, 2024 | 437,000.00 |
| Mar 31, 2024 | 465,000.00 |
| Dec 31, 2023 | 471,000.00 |
| Sep 30, 2023 | 441,000.00 |
| Jun 30, 2023 | 441,000.00 |
| Mar 31, 2023 | 441,000.00 |
| Dec 31, 2022 | 391,000.00 |
| Sep 30, 2022 | 393,000.00 |
| Jun 30, 2022 | 792,000.00 |
| Mar 31, 2022 | 223.00 Mn |
| Dec 31, 2021 | 2.03 Mn |
| Dec 31, 2020 | 139,000.00 |